Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

Alkermes Inc - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 17/12/2007
  • Report Title: Alkermes Inc - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 52
Introduction

Alkermes is a biotechnology company focused on drug development process from a patient-centric perspective, beginning with a thorough understanding of the challenges patients face on a day-to-day basis. The company's acquisition of Medisorb Technologies and Advanced Inhalation Research (AIR) in 1996 and 1996 have resulted Alkermes in emerging as strong player with proven proprietary technologies.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Alkermes develops innovative medicines based on sophisticated drug delivery technologies to enhance therapeutic outcomes in major diseases and improve patient's lives.

    The company has two commercial products: Risperdal Consta (risperidone), a long-acting atypical antipsychotic medication for schizophrenia and Vivitrol (naltrexone for extended-release injectable suspension), the first and only once-monthly injectable medication for the treatment of alcohol dependence

    Its product candidates include ALKS 29 for alcohol dependence, AIR Inhaled Insulin (AIR Insulin) for diabetes, Exenatide LAR for Type 2 diabetes and AIR PTH for Osteoporosis. It enters into collaborations with pharmaceutical and biotechnology companies to develop new product candidates based on existing drugs incorporating its technologies.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic